The effect of SGLT2 inhibitor on diabetic cardiac autonomic neuropathy
Not Applicable
- Conditions
- diabetes mellitus
- Registration Number
- JPRN-UMIN000033541
- Lead Sponsor
- Sakakibara Heart Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) History of SGLT2 inhibitor treatment (2) Associated with severe renal dysfunction (3) Associated with respiratory disease (4) History of cerebral infarction (5) History of urinary / genital infection (6) Women in pregnancy or at risk of becomming pregnant (7) Breast-feeding woment (8) Patients whom researchers rule out as prropriate subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method